FdaApplication
ANDA 209970
Identifiers
- fda_app_no: ANDA209970
Properties
| Property | Value |
|---|---|
| applicant_name | TEVA PHARMACEUTICALS USA INC |
| application_type | ANDA |
| approval_date | 2022-05-06 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| MESALAMINE | MESALAMINE | 375MG | CAPSULE, EXTENDED RELEASE;ORAL |
1 product